Company profile
The Native Antigen Company Limited
The Native Antigen Company
Welcome to The Native Antigen Company. we are world-leading infectious disease reagents from the experts. Whether you need cutting edge reagents for your research or bulk products for manufacturing we can support all of your needs.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Total Exemption Full
Accounts PDF pendingAA | Transaction MzQ0NDc4MzYzMWFkaXF6a2N4 | Paper/PDF filed
Published 27 Nov 2024 10:42
Legacy
Accounts PDF pendingPARENT_ACC | Transaction MzQ0NDc4MzIyNGFkaXF6a2N4 | Paper/PDF filed
Published 25 Nov 2024 02:27
Legacy
OtherAGREEMENT2 | Transaction MzQ0NDc4MzAwN2FkaXF6a2N4 | Paper/PDF filed
Published 25 Nov 2024 02:25
Legacy
OtherGUARANTEE2 | Transaction MzQ0NDc4MjkwOGFkaXF6a2N4 | Paper/PDF filed
Published 25 Nov 2024 02:23
Termination Secretary Company With Name Termination Date
OfficersTM02 | Transaction MzQzNzczMjcwMmFkaXF6a2N4
Published 30 Sep 2024 12:16
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzNjgzNDY3NmFkaXF6a2N4
Published 23 Sep 2024 11:25
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Development of a point-of-care, non-crossreacting Zika diagnostic test
1 Jan 2017 to 30 Sep 2018
At the start of 2016, Zika virus hit the headlines with an outbreak in Brazil far larger than any seen before, causing a huge rise in the number of children born with smaller than average heads and other abnormalities. As this virus is relatively recent, there are very few diagnostic methods of detecting the disease it causes, and most of the currently av...
Development of a novel, rapid and safe neutralising antibody diagnostic kit by The Native Antigen Company
1 Mar 2016 to 28 Feb 2017
Diagnostic tests are a vital component of disease diagnosis and vaccine research. For any test, the important parameters are sensitivity (i.e. the ability of the test to correctly identify a positive sample) and specificity (i.e. its ability to discriminate correctly between different diseases). Most diagnostic tests are simple plate-based assays or pregn...
A novel approach using VLP's to enhance the immunogenicity of peptides for generation of therapeutic Monoclonal antibodies.
1 Aug 2014 to 31 Jul 2015
The global market for therapeutic monoclonal antibodies (mAbs) has become the fastest growing segment of the pharmaceutical industry. The antigen is the lynchpin of therapeutic mAb development, so understanding, controlling and engineering antigens to increase immunogenicity is of vital interest to the pharmaceutical and diagnostic industry. Despite the s...
A novel virus-like particle based mammalian expression system targeted at vaccine development against envelope viruses.
1 Feb 2013 to 31 Jan 2014
The Native Antigen Company (NAC) proposes to examine the technical feasibility of developing a novel mammalian cell expression system which would overcome the current barriers to producing suitable antigens from enveloped viruses for use as vaccine candidates. Our innovative approach would centre on the provision of pure Virus-Like Particles (VLPs) contai...
The purification and production of toxins from emergent Clostridium difficile hypervirulent strains for use in Vaccine Research
1 Jan 2013 to 31 Mar 2014
Clostridium difficile infection (CDI) is a major cause of morbidity and mortality in economically developed countries. CDI is primarily linked with hospital admission and prior antimicrobial treatment. Although significant advances have been made to reduce incidence, a number of hypervirulent and highly transmissible strains have recently emerged. Resulta...
The Native Antigen Company - Native antigens for rapid point of care diagnostics
1 Mar 2012 to 28 Feb 2013
Early detection of infectious disease offers the greatest opportunity to contain potential outbreaks, save lives and decrease the economic burden of healthcare. Rapid diagnostic test kits are one of the most effective ways to achieve this, allowing health care workers or members of the public to identify disease in the community. These tests, usually in t...